We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+13.1%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$822M
AUM Growth
+$213M
(+35%)
Cap. Flow
+$159M
Cap. Flow
% of AUM
19.35%
Top 10 Holdings %
Top 10 Hldgs %
48.5%
Holding
184
New
56
Increased
30
Reduced
32
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$30.7M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$15.8M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$15.4M |
| 4 |
Microsoft
MSFT
|
+$15.2M |
| 5 |
SMAR
Smartsheet Inc.
SMAR
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STKL
SunOpta
STKL
|
+$19.9M |
| 2 |
T-Mobile US
TMUS
|
+$14.5M |
| 3 |
EVA
Enviva Inc.
EVA
|
+$11.3M |
| 4 |
FTAI Aviation
FTAI
|
+$10.4M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$8.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.02% |
| 2 | Healthcare | 12.33% |
| 3 | Communication Services | 6.21% |
| 4 | Utilities | 5.54% |
| 5 | Industrials | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$289M
| $92.4M | 11.24% |
4,250,000
+2,350,000
| +124% | +$45.5M |
|
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
| $71.3M | 8.68% |
180,000
+172,000
| +2,150% | +$66.3M |
|
|
CTLP
3
DELISTED
Cantaloupe
CTLP
| $55.9M | 6.8% |
4,912,753
+1,187,178
| +32% | +$12.5M |
|
|
STKL
4
DELISTED
SunOpta
STKL
| $29.7M | 3.61% |
2,008,000
-1,388,514
| -41% | -$19.9M |
|
|
MBII
5
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $27.9M | 3.39% |
16,692,753
+741,617
| +5% | +$1.54M |
|
|
6
Baidu
BIDU
$35.7B
| $26.2M | 3.19% |
120,500
+117,500
| +3,917% | +$30.7M |
|
7
Dynatrace
DT
$12.7B
| $25.9M | 3.15% |
537,000
+33,000
| +7% | +$1.6M |
|
|
ZEN
8
DELISTED
ZENDESK INC
ZEN
| $23.2M | 2.82% |
175,000
+110,500
| +171% | +$15.8M |
|
9
Micron Technology
MU
$927B
| $23.2M | 2.82% |
262,500
+146,500
| +126% | +$12.4M |
|
|
HZNP
10
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $23M | 2.8% |
250,000
+50,000
| +25% | +$4.22M |
|
|
11
FTAI Aviation
FTAI
$21.8B
| $22.5M | 2.73% |
933,873
-463,716
| -33% | -$10.4M |
|
|
12
T-Mobile US
TMUS
$196B
| $20.1M | 2.45% |
160,500
-114,750
| -42% | -$14.5M |
|
13
AES
AES
$10.6B
| $18.8M | 2.29% |
701,250
-303,750
| -30% | -$8.08M |
|
14
Upland Software
UPLD
$14.4M
| $17.9M | 2.18% |
38,000
-50
| -0.1% | -$24.1K |
|
15
Surgery Partners
SGRY
$2.04B
| $17.8M | 2.16% |
402,000
-15,000
| -4% | -$557K |
|
|
16
Microsoft
MSFT
$2.92T
| $17.7M | 2.16% |
75,000
+65,400
| +681% | +$15.2M |
|
|
CVA
17
DELISTED
Covanta Holding Corporation
CVA
| $16.1M | 1.96% |
1,161,000
+127,000
| +12% | +$1.82M |
|
|
18
Vertex Pharmaceuticals
VRTX
$124B
| $15M | 1.83% |
+70,000
| New | +$15.4M |
|
19
CALL
AstraZeneca
AZN
$267B
| $14.9M | 1.81% |
+150,000
| New | +$15.1M |
|
20
TG Therapeutics
TGTX
$8.4B
| $14.5M | 1.76% |
300,000
-100,000
| -25% | -$4.8M |
|
|
21
CALL
FTAI Aviation
FTAI
$21.8B
| $14M | 1.7% |
579,645
-122,955
| -18% | -$2.75M |
|
|
SMAR
22
DELISTED
Smartsheet Inc.
SMAR
| $11.9M | 1.45% |
+186,000
| New | +$13M |
|
|
23
CALL
Baidu
BIDU
$35.7B
| $10.9M | 1.32% |
+50,000
| New | +$13.1M |
|
24
PagerDuty
PD
$795M
| $10.9M | 1.32% |
+270,000
| New | +$12.3M |
|
25
International Flavors & Fragrances
IFF
$20.2B
| $10.5M | 1.27% |
+75,000
| New | +$9.7M |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Ardsley Advisory Partners held 184 positions worth $822M, up 35% from $609M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Ardsley Advisory Partners deployed $159M of net new capital in Q1 2021, opening 56 new positions and adding to 30 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 70,000 shares worth $15M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 25% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was SunOpta, an estimated $19.9M trimmed.
- Ardsley Advisory Partners's largest Q1 2021 buy was Vertex Pharmaceuticals: 70,000 shares worth $15M.
- Ardsley Advisory Partners added most to Baidu in Q1 2021, an estimated $30.7M increase.
- Ardsley Advisory Partners's biggest Q1 2021 reduction was SunOpta, cutting an estimated $19.9M.
- Ardsley Advisory Partners fully exited Enviva Inc. in Q1 2021, selling an estimated $11.3M.
- Ardsley Advisory Partners's ten largest holdings make up 48% of its $822M portfolio in Q1 2021.
- Ardsley Advisory Partners opened 56 new positions and closed 61 in Q1 2021.
- Ardsley Advisory Partners's portfolio value rose 35% quarter-over-quarter to $822M.
Based on Ardsley Advisory Partners's 13F filing for Q1 2021, filed 17 May 2021.